Evaluation of the association between quantitative mammographic density and breast cancer occurred in different quadrants

Abstract

BackgroundTo investigate the relationship between mammographic density measured in four quadrants of a breast with the location of the occurred cancer.MethodsOne hundred and ten women diagnosed with unilateral breast cancer that could be determined in one specific breast quadrant were retrospectively studied. Women with previous cancer/breast surgery were excluded. The craniocaudal (CC) and mediolateral oblique (MLO) mammography of the contralateral normal breast were used to separate a breast into 4 quadrants: Upper-Outer (UO), Upper-Inner (UI), Lower-Outer (LO), and Lower-Inner (LI). The breast area (BA), dense area (DA), and percent density (PD) in each quadrant were measured by using the fuzzy-C-means segmentation. The BA, DA, and PD were compared between patients who had cancer occurring in different quadrants.ResultsThe upper-outer quadrant had the highest BA (37 ± 15 cm2) and DA (7.1 ± 2.9 cm2), with PD = 20.0 ± 5.8%. The order of BA and DA in the 4 separated quadrants were: UO > UI > LO > LI, and almost all pair-wise comparisons showed significant differences. For tumor location, 67 women (60.9%) had tumor in UO, 16 (14.5%) in UI, 7 (6.4%) in LO, and 20 (18.2%) in LI quadrant, respectively. The estimated odds and the 95% confidence limits of tumor development in the UO, UI, LO and LI quadrants were 1.56 (1.06, 2.29), 0.17 (0.10, 0.29), 0.07 (0.03, 0.15), and 0.22 (0.14, 0.36), respectively. In these 4 groups of women, the order of quadrant BA and DA were all the same (UO > UI > LO > LI), and there was no significant difference in BA, DA or PD among them (all p > 0.05).ConclusionsBreast cancer was most likely to occur in the UO quadrant, which was also the quadrant with highest BA and DA; but for women with tumors in other quadrants, the density in that quadrant was not the highest. Therefore, there was no direct association between quadrant density and tumor occurrence.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-017-3270-0) contains supplementary material, which is available to authorized users.

Analysing the Insights and Assessing the Impact of a Digital Mammography and Tomosynthesis Based 2-year Long Prospective Breast Screening Programme Organised in Western India

“…Lesions in our study were most frequent in the upper outer quadrant, followed by the retromammary region; the upper inner and lower inner quadrants were the next most frequently involved regions, occurring with nearly the same frequency; while the lower outer quadrant was least frequent. Our findings are consistent with previous research by Chan et al, (2017) and Yadav et al, (2018) in their cohort of 110 women who found that the upper outer quadrant was the most common location of the lesions.…”

The poor prognosis of lower-inner quadrant breast cancer in patients who received neoadjuvant chemotherapy

“…From the current literature, how the inner quadrant microenvironment sets the stage for probable tumor formation and enhances the metastatic potential is still unclear. It was already known that breast cancer development in the outer quadrants is much more frequent than that in the inner quadrants, and the investigation of the association between the quadrant site of tumors and quadrant density will be worth conducting (24). Two studies have evaluated breast density in a range of quadrants, but the results were inconsistent with the incidence of cancer (25,26).…”

<p>Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer</p>

“…Breast cancers are most frequently arising from the UOQ of glandular tissues of the breast area. 78 Moreover, breast cancer can also classified into four groups based on Immunohistochemistry (IHC) profile estrogen receptor (ER)/progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2/neu) expression, positive (+) and/or negative (-) such as ER/PR+,Her2+, ER/PR+,Her2-, ER/PR-,Her2+, and ER/PR-,Her2-. 79 About more than 70% of BCs are ER-positive and tamoxifen is the most common and effective therapy for patients with ER-positive breast cancer.…”